370 related articles for article (PubMed ID: 25173930)
21. A yeast model of FUS/TLS-dependent cytotoxicity.
Ju S; Tardiff DF; Han H; Divya K; Zhong Q; Maquat LE; Bosco DA; Hayward LJ; Brown RH; Lindquist S; Ringe D; Petsko GA
PLoS Biol; 2011 Apr; 9(4):e1001052. PubMed ID: 21541368
[TBL] [Abstract][Full Text] [Related]
22. Mutant FUS and ELAVL4 (HuD) Aberrant Crosstalk in Amyotrophic Lateral Sclerosis.
De Santis R; Alfano V; de Turris V; Colantoni A; Santini L; Garone MG; Antonacci G; Peruzzi G; Sudria-Lopez E; Wyler E; Anink JJ; Aronica E; Landthaler M; Pasterkamp RJ; Bozzoni I; Rosa A
Cell Rep; 2019 Jun; 27(13):3818-3831.e5. PubMed ID: 31242416
[TBL] [Abstract][Full Text] [Related]
23. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.
Sun Z; Diaz Z; Fang X; Hart MP; Chesi A; Shorter J; Gitler AD
PLoS Biol; 2011 Apr; 9(4):e1000614. PubMed ID: 21541367
[TBL] [Abstract][Full Text] [Related]
24. Sequestration of PRMT1 and Nd1-L mRNA into ALS-linked FUS mutant R521C-positive aggregates contributes to neurite degeneration upon oxidative stress.
Jun MH; Ryu HH; Jun YW; Liu T; Li Y; Lim CS; Lee YS; Kaang BK; Jang DJ; Lee JA
Sci Rep; 2017 Jan; 7():40474. PubMed ID: 28094300
[TBL] [Abstract][Full Text] [Related]
25. Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfide-isomerase.
Farg MA; Soo KY; Walker AK; Pham H; Orian J; Horne MK; Warraich ST; Williams KL; Blair IP; Atkin JD
Neurobiol Aging; 2012 Dec; 33(12):2855-68. PubMed ID: 22459602
[TBL] [Abstract][Full Text] [Related]
26. Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics.
Baron DM; Kaushansky LJ; Ward CL; Sama RR; Chian RJ; Boggio KJ; Quaresma AJ; Nickerson JA; Bosco DA
Mol Neurodegener; 2013 Aug; 8():30. PubMed ID: 24090136
[TBL] [Abstract][Full Text] [Related]
27. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations.
Kino Y; Washizu C; Aquilanti E; Okuno M; Kurosawa M; Yamada M; Doi H; Nukina N
Nucleic Acids Res; 2011 Apr; 39(7):2781-98. PubMed ID: 21109527
[TBL] [Abstract][Full Text] [Related]
28. Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD.
Fang MY; Markmiller S; Vu AQ; Javaherian A; Dowdle WE; Jolivet P; Bushway PJ; Castello NA; Baral A; Chan MY; Linsley JW; Linsley D; Mercola M; Finkbeiner S; Lecuyer E; Lewcock JW; Yeo GW
Neuron; 2019 Sep; 103(5):802-819.e11. PubMed ID: 31272829
[TBL] [Abstract][Full Text] [Related]
29. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
Fiesel FC; Kahle PJ
FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
[TBL] [Abstract][Full Text] [Related]
30. Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis.
Nomura T; Watanabe S; Kaneko K; Yamanaka K; Nukina N; Furukawa Y
J Biol Chem; 2014 Jan; 289(2):1192-202. PubMed ID: 24280224
[TBL] [Abstract][Full Text] [Related]
31. Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein.
Yang S; Warraich ST; Nicholson GA; Blair IP
Int J Biochem Cell Biol; 2010 Sep; 42(9):1408-11. PubMed ID: 20541619
[TBL] [Abstract][Full Text] [Related]
32. M
Di Timoteo G; Giuliani A; Setti A; Biagi MC; Lisi M; Santini T; Grandioso A; Mariani D; Castagnetti F; Perego E; Zappone S; Lattante S; Sabatelli M; Rotili D; Vicidomini G; Bozzoni I
Nat Commun; 2024 Jun; 15(1):5033. PubMed ID: 38866783
[TBL] [Abstract][Full Text] [Related]
33. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.
Bosco DA; Lemay N; Ko HK; Zhou H; Burke C; Kwiatkowski TJ; Sapp P; McKenna-Yasek D; Brown RH; Hayward LJ
Hum Mol Genet; 2010 Nov; 19(21):4160-75. PubMed ID: 20699327
[TBL] [Abstract][Full Text] [Related]
34. FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis.
Kryndushkin D; Wickner RB; Shewmaker F
Protein Cell; 2011 Mar; 2(3):223-36. PubMed ID: 21452073
[TBL] [Abstract][Full Text] [Related]
35. Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1.
Tibshirani M; Tradewell ML; Mattina KR; Minotti S; Yang W; Zhou H; Strong MJ; Hayward LJ; Durham HD
Hum Mol Genet; 2015 Feb; 24(3):773-86. PubMed ID: 25274782
[TBL] [Abstract][Full Text] [Related]
36. FUS/TLS assembles into stress granules and is a prosurvival factor during hyperosmolar stress.
Sama RR; Ward CL; Kaushansky LJ; Lemay N; Ishigaki S; Urano F; Bosco DA
J Cell Physiol; 2013 Nov; 228(11):2222-31. PubMed ID: 23625794
[TBL] [Abstract][Full Text] [Related]
37. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA.
Kim SH; Shanware NP; Bowler MJ; Tibbetts RS
J Biol Chem; 2010 Oct; 285(44):34097-105. PubMed ID: 20720006
[TBL] [Abstract][Full Text] [Related]
38. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
[TBL] [Abstract][Full Text] [Related]
39. FUS is sequestered in nuclear aggregates in ALS patient fibroblasts.
Schwartz JC; Podell ER; Han SS; Berry JD; Eggan KC; Cech TR
Mol Biol Cell; 2014 Sep; 25(17):2571-8. PubMed ID: 25009283
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and pathological characteristics of FUS/TLS-associated amyotrophic lateral sclerosis (ALS)].
Murayama S
Rinsho Shinkeigaku; 2010 Nov; 50(11):948-50. PubMed ID: 21921522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
